QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
NASDAQ:BIOL

BIOLASE (BIOL) Short Interest Ratio & Short Volume

$1.74
+0.03 (+1.75%)
(As of 09/21/2023 ET)
Compare
Today's Range
$1.56
$2.10
50-Day Range
$1.71
$675.00
52-Week Range
$1.56
$279.00
Volume
2.19 million shs
Average Volume
132,403 shs
Market Capitalization
$1.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$513.50

BIOLASE Short Interest Data

Current Short Volume
161,600 shares
Previous Short Volume
154,100 shares
Change Vs. Previous Month
+4.87%
Dollar Volume Sold Short
$706,192.00
Short Interest Ratio / Days to Cover
0.7
Last Record Date
August 31, 2023
Outstanding Shares
1,040,000 shares
Float Size
1,000,000 shares
Short Percent of Float
16.16%
Today's Trading Volume
2,194,421 shares
Average Trading Volume
132,403 shares
Today's Volume Vs. Average
1,657%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling BIOLASE ?

Sign up to receive the latest short interest report for BIOLASE and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BIOL Short Interest Over Time

BIOL Days to Cover Over Time

BIOL Percentage of Float Shorted Over Time


BIOLASE (NASDAQ:BIOL) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2023161,600 shares $706,192.00 +4.9%16.2%0.7 $4.37
8/15/2023154,100 shares $947,715.00 -61.4%15.4%0.7 $6.15
7/31/2023399,400 shares $2.43 million -87.2%40.2%2.1 $6.09
7/15/20233,110,000 shares $270,259.00 -44.4%3.8%0.4 $0.09
6/30/20235,590,000 shares $395,213.00 +589.1%6.9%0.7 $0.07
6/15/2023811,200 shares $64,084.80 -61.2%1.1%0.2 $0.08
5/31/20232,090,000 shares $170,335.00 +145.4%8.0%0.6 $0.08
5/15/2023851,600 shares $183,008.84 +4.4%3.7%0.5 $0.21
4/30/2023815,700 shares $203,925.00 +219.5%4.1%0.8 $0.25
4/15/2023255,300 shares $61,833.66 +140.9%1.3%0.3 $0.24
3/31/2023106,000 shares $29,807.20 +127.0%0.5%0.2 $0.28
3/15/202346,700 shares $18,213.00 -59.2%0.2%0.1 $0.39
2/28/2023114,500 shares $58,395.00 -42.4%0.6%0.2 $0.51
2/15/2023198,900 shares $101,399.22 -29.1%1.0%0.3 $0.51
1/31/2023280,400 shares $152,313.28 -31.9%1.4%0.5 $0.54
1/15/2023411,800 shares $175,591.52 -36.7%12.8%0.9 $0.43
12/30/2022650,300 shares $422,695.00 -7.1%9.3%2.7 $0.65
12/15/2022700,100 shares $467,316.75 +108.5%10.0%5.1 $0.67
11/30/2022335,800 shares $324,382.80 +144.2%4.8%3 $0.97
11/15/2022137,500 shares $247,500.00 +8.4%2.0%1.8 $1.80
10/31/2022126,900 shares $248,724.00 -2.0%1.9%3.7 $1.96
10/15/2022129,500 shares $268,065.00 +5.0%1.9%3.9 $2.07
9/30/2022123,300 shares $299,619.00 +5.7%1.8%3.7 $2.43
9/15/2022116,700 shares $378,108.00 +6.4%1.7%3.2 $3.24
8/31/2022109,700 shares $424,539.00 -23.9%1.6%3.1 $3.87
8/15/2022144,200 shares $733,257.00 -22.6%2.1%3.9 $5.09
7/31/2022186,300 shares $825,309.00 -13.2%2.8%4.6 $4.43
7/15/2022214,500 shares $890,175.00 -13.2%3.2%3.7 $4.15
6/30/2022247,200 shares $1.13 million +3.5%3.3%4.2 $4.58
6/15/2022238,800 shares $1.03 million -14.7%4.0%4.2 $4.31
5/31/2022280,100 shares $1.35 million -0.4%4.6%4.4 $4.83
5/15/2022281,300 shares $1.12 million -45.3%4.7%4.3 $3.99
4/30/2022514,100 shares $2.36 million -89.5%8.5%8.5 $4.60
4/15/20224,910,000 shares $1.51 million +1.7%N/A4.3 $0.31
3/31/20224,830,000 shares $1.71 million +14.2%N/A3.8 $0.35
3/15/20224,230,000 shares $1.35 million -16.4%N/A2 $0.32
2/28/20225,060,000 shares $1.78 million +14.0%3.4%2.3 $0.35
2/15/20224,440,000 shares $1.77 million -18.2%3.0%1.6 $0.40
1/31/20225,430,000 shares $2.01 million -7.8%3.6%1.7 $0.37
1/15/20225,890,000 shares $2.37 million -11.4%3.9%1.8 $0.40













BIOL Short Interest - Frequently Asked Questions

What is BIOLASE's current short interest?

Short interest is the volume of BIOLASE shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 161,600 shares of BIOL short. 16.16% of BIOLASE's shares are currently sold short. Learn More on BIOLASE's current short interest.

What is a good short interest ratio for BIOLASE?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOL shares currently have a short interest ratio of 1.0. Learn More on BIOLASE's short interest ratio.

What is a good short interest percentage for BIOLASE?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.16% of BIOLASE's floating shares are currently sold short.

Is BIOLASE's short interest increasing or decreasing?

BIOLASE saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 161,600 shares, an increase of 4.9% from the previous total of 154,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BIOLASE's float size?

BIOLASE currently has issued a total of 1,040,000 shares. Some of BIOLASE's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BIOLASE currently has a public float of 1,000,000 shares.

How does BIOLASE's short interest compare to its competitors?

16.16% of BIOLASE's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BIOLASE: Bone Biologics Co. (0.28%), OpGen, Inc. (3.10%), Allarity Therapeutics, Inc. (0.91%), ReShape Lifesciences Inc. (1.12%), Akanda Corp. (3.39%), SQZ Biotechnologies (3.77%), Infinity Pharmaceuticals, Inc. (2.43%), Motus GI Holdings, Inc. (2.82%), Scopus BioPharma Inc. (0.84%), Avalo Therapeutics, Inc. (5.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short BIOLASE stock?

Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BIOLASE?

A short squeeze for BIOLASE occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOL, which in turn drives the price of the stock up even further.

How often is BIOLASE's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOL, twice per month. The most recent reporting period available is August, 31 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BIOL) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -